Novira Therapeutics

BiotechnologySeries ADoylestown, USnoviratherapeutics.com

Latest round

Series A

Last raised

Feb 2014

Total raised

$53M

Investors

8

About Novira Therapeutics

Established in 2009, Novira Therapeutics is based in Pennsylvania, US and operates as an anti-viral drug discovery company focused on the discovery of novel, first-in-class therapeutics for the treatment of HBV and HIV.

Who invested in Novira Therapeutics

8 investors across 6 rounds

See all investors in Novira Therapeutics

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series A

    Feb 11, 2014

    Amount

    $28M

    Investors

    Locked

  2. Series A

    Mar 25, 2013

    Amount

    $7.5M

    Investors

    Locked

  3. Series A

    Oct 9, 2012

    Amount

    $3.3M

    Investors

    Locked

  4. Series A

    Aug 24, 2012

    Amount

    $11M

    Investors

    Locked

  5. Seed

    Jul 26, 2011

    Amount

    $2.5M

    Investors

    Locked

  6. Seed

    Mar 30, 2009

    Amount

    $0.5M

    Investors

    Locked

Questions about Novira Therapeutics

Who invested in Novira Therapeutics?

Novira Therapeutics has 8 investors on record across 6 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Novira Therapeutics raised?

Novira Therapeutics has raised 6 venture rounds. Sign up free to see how much each round raised and the total.

When did Novira Therapeutics last raise money?

Novira Therapeutics's most recent round on record is a Series A, in Feb 2014.

What does Novira Therapeutics do?

Established in 2009, Novira Therapeutics is based in Pennsylvania, US and operates as an anti-viral drug discovery company focused on the discovery of novel, first-in-class therapeutics for the treatment of HBV and HIV.

Where is Novira Therapeutics headquartered?

Novira Therapeutics is headquartered in Doylestown, US.

Which VCs invest in companies like Novira Therapeutics?

Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Novira Therapeutics's stage. Their profiles are linked below.

Raising like Novira Therapeutics? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.